Dementia is a group of diseases that involve having trouble with memory, thinking, reasoning and other brain functions. It is ...

Cognition Therapeutics’ therapy showed up to a 129% slowing of cognitive decline in mild Alzheimer’s disease patients.

These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...

Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, ...

Zervimesine’s impact on debilitating DLB behavioral symptoms highlighted in podium presentation -- Plasma p-tau217 levels can identify Alzheimer’s patients most likely to benefit from zervimesine ...

Alzheimer's disease affects more than 6 million Americans, and emerging research identifies Obstructive Sleep Apnea (OSA) as ...

Treatment with memantine in a small cohort of individuals with post-traumatic headache led to fewer average headache days per month and positively affected post-concussion symptoms, according to a ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. A new stem cell ...

The reason I can identify has nothing to do with my canoodling at a concert with someone other than the man with whom I ...

As Alzheimer's disease progresses, behavioral and psychiatric issues become common, distressing, and even dangerous for patients. Management is complex.

With the advent of the college of osteopathic medicine that’s coming here, I don’t think I would be exaggerating to say that ...

He had a fall at home in 2019 which aggravated injuries from a near-fatal quad bike crash in 2003. Parkinson’s UK chief ...